Which Factors Predict Primary Nonadherence to Medications? Which Factors Predict Primary Nonadherence to Medications?
Most medication adherence research to date has focused on secondary nonadherence, and primary medication nonadherence has been identified as a major research gap.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 21, 2023 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Source Type: news
Paxlovid, Lagevrio Benefit COVID Outpatients in Omicron Era Paxlovid, Lagevrio Benefit COVID Outpatients in Omicron Era
The American College of Physicians has issued an updated version of its living, rapid practice point guideline on the best treatment options for outpatients with confirmed COVID-19.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 19, 2023 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
Does Adding Ipilimumab to Nivolumab Improve Cancer Outcomes? Does Adding Ipilimumab to Nivolumab Improve Cancer Outcomes?
Nivolumab alone may offer equivalent clinical outcomes and lower toxicity than nivolumab plus ipilimumab in many advanced cancers other than melanoma, a new meta-analysis suggests.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 18, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
Turmeric May Be as Effective as Omeprazole for Dyspepsia Turmeric May Be as Effective as Omeprazole for Dyspepsia
Curcumin, a compound found in the spice turmeric, may be as effective as the proton pump inhibitor omeprazole for treating indigestion.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 12, 2023 Category: Drugs & Pharmacology Tags: Internal Medicine News Source Type: news
HCQ Blood Level'Sweet Spot' May Maximize Efficacy in Lupus HCQ Blood Level'Sweet Spot' May Maximize Efficacy in Lupus
Researchers identified a blood-level reference range linked with 71% lower odds of active lupus.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 12, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
Colchicine Still Needed in Allopurinol Up-Titration Strategy Colchicine Still Needed in Allopurinol Up-Titration Strategy
Patients taking colchicine had fewer gout flares than did those taking placebo for the first 6 months, but the number of flares evened out between the two groups over a 12-month period.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 11, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
Abortions for Out-of-State Patients Up in Massachusetts Abortions for Out-of-State Patients Up in Massachusetts
The state is seeing an almost 40% increase in abortions among patients from outside of the state following the Supreme Court decision allowing states to ban the procedure.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 6, 2023 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
FDA Approves Canakinumab for Gout Flares FDA Approves Canakinumab for Gout Flares
Canakinumab is first biologic in the US approved for treating gout flares.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 31, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
PPIs Linked to Long-Term Infection in Kids PPIs Linked to Long-Term Infection in Kids
Experts said the new data show the importance of limiting use of this type of acid suppressant in children.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 29, 2023 Category: Drugs & Pharmacology Tags: Pediatrics News Source Type: news
Nilotinib Linked to Metabolic Syndrome and CVD in CML Nilotinib Linked to Metabolic Syndrome and CVD in CML
Investigators suggest using other TKIs in patients with preexisting diabetes and hyperlipidemia.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 29, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
Long-Term Outcomes of Pegcetacoplan for GA Show Promise Long-Term Outcomes of Pegcetacoplan for GA Show Promise
Results of the 30-month data cut of the 3-year GALE open-label extension trial of pegcetacoplan for geographic atrophy showed that the drug produced clinically meaningful reductions in lesion growth.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 8, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology News Source Type: news
Biosimilars Comparable to Aflibercept in Macular Disease Biosimilars Comparable to Aflibercept in Macular Disease
Phase 3 registration trials found the comparability of two biosimilars to reference aflibercept in terms of efficacy, safety, pharmacokinetics, and immunogenicity.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 3, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology Source Type: news
Higher Aflibercept Dose Safe as 2 mg Higher Aflibercept Dose Safe as 2 mg
The PULSAR trial of a higher dosage formulation extended the treatment interval to 12 or 16 weeks.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 3, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology News Source Type: news
Study Shows Vision, Anatomy Stable With Port System for AMD Study Shows Vision, Anatomy Stable With Port System for AMD
Recalled in 2022, a port delivery system for ranibizumab to treat wet AMD demonstrated that vision and retinal anatomy remained stable in patients who had the device for 5 years.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 2, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology News Source Type: news
Study: AMD Gene Therapy Demonstrates Vision Stabilization Study: AMD Gene Therapy Demonstrates Vision Stabilization
An early gene therapy trial reported maintenance of vision, reduced retinal inflammation, and detectable therapeutic protein levels 9 months after treatment for age-related macular degeneration.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 1, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology News Source Type: news
